History of Regorafenib
Regorafenib (Stivarga) falls under the oral multi-kinase inhibitor, which was developed by Bayer which specifically targets the...
top of page
bottom of page
Regorafenib (Stivarga) falls under the oral multi-kinase inhibitor, which was developed by Bayer which specifically targets the...